Table II.
Characteristics | All RPL patients | ≤500 μg/l | 501–3000 μg/l | >3000 µg/l | P a |
---|---|---|---|---|---|
(N = 119) | (N = 102) | (N = 46) | |||
Age, years, mean ( SD) | 33.2 (5.3) | 33.4 (5.3) | 32.8 (5.5) | 33.6 (5.1) | 0.84 |
BMI, b kg/m2, median (P10/P90) | 25.4 (20.0/34.5) | 25.5 (19.5/34.0 | 25.0 (20.0/35.0) | 26.5 (20.5/33.5) | 0.20 |
Maternal smoking, N (%) | 35 (13.1) | 16 (13.4) | 13 (12.7) | 6 (13.0) | 1.0 |
No. of consecutive pregnancy losses, median, N (range) | 3 (3–13) | 3 (3–13) | 3 (3–8) | 4 (3–10) | 0.87 |
pRPL, N (%) | 144 (53.9) | 65 (54.6) | 59 (57.8) | 20 (43.5) | 0.26 |
sRPL, N (%) | 123 (46.1) | 54 (45.4) | 43 (42.2) | 26 (56.5) | |
Treatment after admission, N (%) | |||||
IVIG | 85 (31.8) | 40 (33.6) | 30 (29.4) | 15 (32.6) | 0.79 |
ART | 78 (29.2) | 37 (31.1) | 30 (29.4) | 11 (23.9) | 0.66 |
RPL, recurrent pregnancy loss; pRPL, primary RPL; sRPL, secondary RPL; IVIG, intravenous immunoglobulin; ART, IVF and ICSI; p-MBL, plasma mannose-binding lectin.
P-value for differences between the three RPL subgroups according to p-MBL level.
Two missing values.